Oboshi, et al., GANN 58:315-21 (1967). Antitumor Studies on Mitomycin Derivs.II Effect on Solid Tumor of Sarcoma-180. |
Usubuchi, et al., GANN58:307-13 (1967). Antitumor Studies on Mitomycin Derivs. I Effect on Hirosaki Ascites Sarcoma. |
Matsui, et al., J. Antibiotics 21(3):189-98 (1968). Studies on Mitomycins.III Synth. and Props. of Mitomycin Derivatives. |
Cheng, et al., J. Med Chem.20(6):767-70(1977), Compar. Stereochem. in Aziridine Ring Openings of N-Methylmitomycin A and 7-Methoxy-1 2-(N-Methylaziridino) Mitosene. |
Iyengar et al., J.Med. Chem. 26:16-20 (1983), Mitomycin C and Porforomycin Analogues with Substituted 7-Ethylamines. |
Schein et al., in "Mitomycin C: Current Status and New Developments"; eds., Carter et al., Acad. Press, N.Y., 1979, pp. 133-143. |
Sami et al., J. Med. Chem. 27:701-8 (1984), Mitomycin C Analogues with Aryl Substituents on the 7-Amino Group. |
Suami et al., J.Med.Chem. 22(3): 247-50 (1979), Synthesis and Activities of Antitumor Agents. |
Anderson et al., Cancer Res. 35:761-5 (1975), Chlorozotocin, An Anti-Tumor Agent with Modified Bone Marrow Toxicity. |
Panasci et al., J. Clin. Invest.64:1103-11 (1979). |
Chlorozotocin. Reduced Bone Marrow Toxicity in Mice. |
Kinoshita et al., J.Med.Chem. 14(2):103-12 (1971), Mitomycin Derivatives, 1. Prep'n of Mitosane & Mitosene Cpds & Biol. Actions. |
Weiss et al., J.Med.Chem., 11:742-6 (1968), Mitomycin Antibiotics, Synthetic Studies, XXII, Antibacterial Structure-Activity Relationships in the Indoloquinone Series. |
Patrick et al., J.Amer.Chem.Soc. 86:1889-90 (1964). Aziridinomitosenes: A New Class of Antibiotics Related to the Mitomycins. |
Driscoll et al., Cancer Chemotherap. Rep. 4:3-4 (1974). Quinone Structure-Antitumor Activity Relationships. |
Kojima et al., Cancer Chemotherap.Rep. 3:111-119 (1972). Influence of Schedule of Admin. of Mitomycin C in Treatment of L1210 Leukemia. |
Goldin et al., NCI-EORTC Sympos. On Mitomycin C, Brussels 1981, pp. 1-17, Preclinical Studies with Mitomycin C and Derivatives. |
Kojima et al., Cancer Chemotherap.Reps. 3:121-135 (1972), Some Structure-Activity Relationships for Mitomycin C Derivatives in Treatment of LI2I0 Leukemia. |
Kisner et al. Mit.C in Treatment of Gastric and Pancreatic Carcinomas, NCI-EORTC Symp. Mit.C, Brussels, 1981, pp. 64-75. |
DeLena et al., Single Agent Activity of Mit.C in Breast Cancer, NCI-EORTC Symp. Mit.C, Brussels, 1981, pp. 89-96. |
Israel et al., Mit.C in Nonsmall Cell Lung Cancer, NCI-EORTC Sympos. Mit.C. Brussels. 1981, pp. 106-112. |
Godfrey, Mito.C in Breast Cancer, in Mit.C: Current Status and New Developments, Carter et al., eds., Acad. Press, N.Y. 1979, pp. 91-99. |
Samson, Clin. Studies of Mit.C in Adv. Adenoarcinoma of the Lung, in Mit.C:, Current Status and New Developments, Carter et al., eds., Acad. Press, N.Y. 1979, pp. 121-127. |